{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:04:14Z","timestamp":1789434254272,"version":"build-2803163510"},"reference-count":185,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":80,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08490-7","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T14:34:58Z","timestamp":1782570898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Translational human gut microbiome research: What are the missing pieces of the puzzle?"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7285-0029","authenticated-orcid":false,"given":"Marina","family":"Fassarella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hauke","family":"Smidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"issue":"1","key":"8490_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cmet.2025.10.011","volume":"38","author":"M Van Hul","year":"2026","unstructured":"Van Hul M, Cani PD. From microbiome to metabolism: bridging a two-decade translational gap. Cell Metab. 2026;38(1):14\u201332. https:\/\/doi.org\/10.1016\/j.cmet.2025.10.011.","journal-title":"Cell Metab"},{"issue":"8","key":"8490_CR2","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41575-025-01077-5","volume":"22","author":"Y Sanz","year":"2025","unstructured":"Sanz Y, Cryan JF, Deschasaux-Tanguy M, Elinav E, Lambrecht R, Veiga P. The gut microbiome connects nutrition and human health. Nat Rev Gastroenterol Hepatol. 2025;22(8):534\u201355. https:\/\/doi.org\/10.1038\/s41575-025-01077-5.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"8490_CR3","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41591-025-03615-9","volume":"31","author":"JA Gilbert","year":"2025","unstructured":"Gilbert JA, Azad MB, B\u00e4ckhed F, Blaser MJ, Byndloss M, Chiu CY, et al. Clinical translation of microbiome research. Nat Med. 2025;31(4):1099\u2013113. https:\/\/doi.org\/10.1038\/s41591-025-03615-9.","journal-title":"Nat Med"},{"key":"8490_CR4","doi-asserted-by":"publisher","unstructured":"Khelfaoui I, Wang W, Shehata AI, Meskher H, El Basuini MF, Mohamed AMA, et al. STROBE-causal machine learning for the human microbiome: systematic review on methodological innovations and validation frameworks. Front Microbiol. 2026;17:- 2026. https:\/\/doi.org\/10.3389\/fmicb.2026.1705116.","DOI":"10.3389\/fmicb.2026.1705116"},{"issue":"2","key":"8490_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41564-024-01896-3","volume":"10","author":"AL Pribyl","year":"2025","unstructured":"Pribyl AL, Hugenholtz P, Cooper MA. A decade of advances in human gut microbiome-derived biotherapeutics. Nat Microbiol. 2025;10(2):301\u201312. https:\/\/doi.org\/10.1038\/s41564-024-01896-3.","journal-title":"Nat Microbiol"},{"key":"8490_CR6","doi-asserted-by":"publisher","unstructured":"de Vos Wm, de Vos Ea, de Vos WM, de Vos EA. Role of the intestinal microbiome in health and disease: from correlation to causation. Nutr Rev. 2012;70(1):S45\u201356. https:\/\/doi.org\/10.1111\/j.1753-4887.2012.00505.x.","DOI":"10.1111\/j.1753-4887.2012.00505.x"},{"issue":"7684","key":"8490_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nature25019","volume":"552","author":"NK Surana","year":"2017","unstructured":"Surana NK, Kasper DL. Moving beyond microbiome-wide associations to causal microbe identification. Nature. 2017;552(7684):244\u201347. https:\/\/doi.org\/10.1038\/nature25019.","journal-title":"Nature"},{"issue":"6","key":"8490_CR8","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.3390\/microorganisms9061302","volume":"9","author":"PD Cani","year":"2021","unstructured":"Cani PD, Moens de Hase E, Van Hul M. Gut microbiota and host metabolism: from proof of concept to therapeutic intervention. Microorganisms. 2021;9(6):1302. https:\/\/doi.org\/10.3390\/microorganisms9061302.","journal-title":"Microorganisms"},{"issue":"3","key":"8490_CR9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1136\/gutjnl-2020-321747","volume":"70","author":"M Fassarella","year":"2021","unstructured":"Fassarella M, Blaak EE, Penders J, Nauta A, Smidt H, Zoetendal EG. Gut microbiome stability and resilience: elucidating the response to perturbations in order to modulate gut health. Gut. 2021;70(3):595\u2013605. https:\/\/doi.org\/10.1136\/gutjnl-2020-321747.","journal-title":"Gut"},{"issue":"2","key":"8490_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41588-020-00763-1","volume":"53","author":"A Kurilshikov","year":"2021","unstructured":"Kurilshikov A, Medina-Gomez C, Bacigalupe R, Radjabzadeh D, Wang J, Demirkan A, et al. Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat Genet. 2021;53(2):156\u201365. https:\/\/doi.org\/10.1038\/s41588-020-00763-1.","journal-title":"Nat Genet"},{"issue":"7695","key":"8490_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nature25973","volume":"555","author":"D Rothschild","year":"2018","unstructured":"Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature. 2018;555(7695):210\u201315. https:\/\/doi.org\/10.1038\/nature25973.","journal-title":"Nature"},{"issue":"2","key":"8490_CR12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1053\/j.gastro.2020.09.057","volume":"160","author":"F Shanahan","year":"2021","unstructured":"Shanahan F, Ghosh TS, O\u2019Toole PW. The healthy microbiome\u2014what is the definition of a healthy gut microbiome? Gastroenterology. 2021;160(2):483\u201394. https:\/\/doi.org\/10.1053\/j.gastro.2020.09.057.","journal-title":"Gastroenterology"},{"issue":"5","key":"8490_CR13","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41575-026-01176-x","volume":"23","author":"ML Marco","year":"2026","unstructured":"Marco ML, Cunningham M, Bischoff SC, Clarke G, Delzenne N, Lewis JD, et al. The International scientific Association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of gut health. Nat Rev Gastroenterol Hepatol. 2026;23(5):432\u201348. https:\/\/doi.org\/10.1038\/s41575-026-01176-x.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"8490_CR14","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41579-018-0029-9","volume":"16","author":"R Knight","year":"2018","unstructured":"Knight R, Vrbanac A, Taylor BC, Aksenov A, Callewaert C, Debelius J, et al. Best practices for analysing microbiomes. Nat Rev Microbiol. 2018;16(7):410\u201322. https:\/\/doi.org\/10.1038\/s41579-018-0029-9.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"8490_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41522-025-00683-0","volume":"11","author":"J Rodriguez","year":"2025","unstructured":"Rodriguez J, Cordaillat-Simmons M, Pot B, Druart C. The regulatory framework for microbiome-based therapies: insights into European regulatory developments. NPJ Biofilms Microbiomes. 2025;11(1):53. https:\/\/doi.org\/10.1038\/s41522-025-00683-0.","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"5","key":"8490_CR16","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.cell.2025.01.038","volume":"188","author":"S Turjeman","year":"2025","unstructured":"Turjeman S, Rozera T, Elinav E, Ianiro G, Koren O. From big data and experimental models to clinical trials: iterative strategies in microbiome research. Cell. 2025;188(5):1178\u201397. https:\/\/doi.org\/10.1016\/j.cell.2025.01.038.","journal-title":"Cell"},{"issue":"11","key":"8490_CR17","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/s41591-021-01552-x","volume":"27","author":"C Mirzayi","year":"2021","unstructured":"Mirzayi C, Renson A, Furlanello C, Sansone S-A, Zohra F, Elsafoury S, et al. Reporting guidelines for human microbiome research: the STORMS checklist. Nat Med. 2021;27(11):1885\u201392. https:\/\/doi.org\/10.1038\/s41591-021-01552-x.","journal-title":"Nat Med"},{"issue":"1","key":"8490_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41392-024-01946-6","volume":"9","author":"Z Ma","year":"2024","unstructured":"Ma Z, Zuo T, Frey N, Rangrez AY. A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation. Sig Transduct Target Ther. 2024;9(1):237. https:\/\/doi.org\/10.1038\/s41392-024-01946-6.","journal-title":"Sig Transduct Target Ther"},{"issue":"5","key":"8490_CR19","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41591-021-01258-0","volume":"27","author":"JE Wilkinson","year":"2021","unstructured":"Wilkinson JE, Franzosa EA, Everett C, Li C, Bae S, Berzansky I, et al. A framework for microbiome science in public health. Nat Med. 2021;27(5):766\u201374. https:\/\/doi.org\/10.1038\/s41591-021-01258-0.","journal-title":"Nat Med"},{"key":"8490_CR20","doi-asserted-by":"publisher","unstructured":"Bautista J, Echeverr\u00eda CE, Maldonado-Noboa I, Ojeda-Mosquera S, Hidalgo-Tinoco C, L\u00f3pez-Cort\u00e9s A. The human microbiome in clinical translation: from bench to bedside. Front Microbiol. 2025;16:- 2025. https:\/\/doi.org\/10.3389\/fmicb.2025.1632435.","DOI":"10.3389\/fmicb.2025.1632435"},{"issue":"1","key":"8490_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s41231-023-00153-9","volume":"8","author":"A Acharjee","year":"2023","unstructured":"Acharjee A. Translational research and key aspects to make it successful. Transl Med Commun. 2023;8(1):19. https:\/\/doi.org\/10.1186\/s41231-023-00153-9.","journal-title":"Transl Med Commun"},{"issue":"1","key":"8490_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12910-022-00761-4","volume":"23","author":"B Groot","year":"2022","unstructured":"Groot B, Abma T. Ethics framework for citizen science and public and patient participation in research. BMC Med Ethics. 2022;23(1):23. https:\/\/doi.org\/10.1186\/s12910-022-00761-4.","journal-title":"BMC Med Ethics"},{"issue":"1","key":"8490_CR23","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12967-025-06308-6","volume":"23","author":"L Abualigah","year":"2025","unstructured":"Abualigah L, Alomari SA, Almomani MH, Zitar RA, Saleem K, Migdady H, et al. Artificial intelligence-driven translational medicine: a machine learning framework for predicting disease outcomes and optimizing patient-centric care. J Transl Med. 2025;23(1):302. https:\/\/doi.org\/10.1186\/s12967-025-06308-6.","journal-title":"J Transl Med"},{"issue":"9","key":"8490_CR24","doi-asserted-by":"publisher","first-page":"102072","DOI":"10.1016\/j.jacadv.2025.102072","volume":"4","author":"J Nikolovski","year":"2025","unstructured":"Nikolovski J, Navar Ann M, Steinhubl S, Baca-Motes K, Curtis Anne B, Peterson Eric D, et al. The Heartline experience. JACC: Adv. 2025;4(9):102072. https:\/\/doi.org\/10.1016\/j.jacadv.2025.102072.","journal-title":"JACC: Adv"},{"issue":"24","key":"8490_CR25","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1001\/jama.2022.9265","volume":"327","author":"E Basch","year":"2022","unstructured":"Basch E, Schrag D, Henson S, Jansen J, Ginos B, Stover AM, et al. Effect of electronic symptom monitoring on patient-reported outcomes among patients with metastatic cancer: a randomized clinical trial. JAMA. 2022;327(24):2413\u201322. https:\/\/doi.org\/10.1001\/jama.2022.9265.","journal-title":"JAMA"},{"issue":"8","key":"8490_CR26","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1038\/s41591-022-01945-6","volume":"28","author":"AS Anderson","year":"2022","unstructured":"Anderson AS. A lightspeed approach to pandemic drug development. Nat Med. 2022;28(8):1538\u20131538. https:\/\/doi.org\/10.1038\/s41591-022-01945-6.","journal-title":"Nat Med"},{"key":"8490_CR27","unstructured":"National center for advancing translational Sciences. Translational science principles: national Institutes of health. 2025. Available from: https:\/\/ncats.nih.gov\/about\/about-translational-science\/principles."},{"issue":"1","key":"8490_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12967-021-02910-6","volume":"19","author":"D Hartl","year":"2021","unstructured":"Hartl D, de Luca V, Kostikova A, Laramie J, Kennedy S, Ferrero E, et al. Translational precision medicine: an industry perspective. J Transl Med. 2021;19(1):245. https:\/\/doi.org\/10.1186\/s12967-021-02910-6.","journal-title":"J Transl Med"},{"key":"8490_CR29","unstructured":"FDA-NIH Biomarker Working Group BEST (biomarkers. EndpointS, and other tools). Resource [internet] Silver Spring (MD): food and Drug Administration (US); 2016- Available from: Co-published by National Institutes of health (US). 2016. https:\/\/wwwncbinlmnihgov\/books\/NBK326791\/toc Bethesda (MD)."},{"issue":"7","key":"8490_CR30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/01.gim.0000179941.44494.73","volume":"7","author":"S Sanderson","year":"2005","unstructured":"Sanderson S, Zimmern R, Kroese M, Higgins J, Patch C, Emery J. How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom. Genet Med. 2005;7(7):495\u2013500. https:\/\/doi.org\/10.1097\/01.gim.0000179941.44494.73.","journal-title":"Genet Med"},{"key":"8490_CR31","volume-title":"Critical appraisal of epidemiological studies and clinical trials","author":"EM Confounding","year":"2025","unstructured":"Confounding EM. Critical appraisal of epidemiological studies and clinical trials. 5. Oxford University Press; 2025.","edition":"5"},{"key":"8490_CR32","unstructured":"Food and Drug Administration (FDA). Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. 2009. Silver Spring, MD: U.S. Department of Health and Human Services."},{"issue":"4","key":"8490_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/bmjebm-2022-112068","volume":"28","author":"VM Montori","year":"2023","unstructured":"Montori VM, Ruissen MM, Hargraves IG, Brito JP, Kunneman M. Shared decision-making as a method of care. BMJ EBM. 2023;28(4):213\u201317. https:\/\/doi.org\/10.1136\/bmjebm-2022-112068.","journal-title":"BMJ EBM"},{"key":"8490_CR34","unstructured":"World Health Organization. WHO handbook for guideline development Geneva: World Health Organization; 2014 [2nd]. Available from. https:\/\/www.who.int\/publications\/i\/item\/9789241548960."},{"key":"8490_CR35","unstructured":"World Health Organization, editor Summary reports on proceedings minutes and final acts of the International Health Conference held in New York from 19 June to 22 July 1946. International Health Conference; 1948, 19 June-22 July 1946, New York: United Nations. World Health Organization; Interim Commission."},{"issue":"4","key":"8490_CR36","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.mayocp.2023.02.005","volume":"99","author":"LJ Finney Rutten","year":"2024","unstructured":"Finney Rutten LJ, Ridgeway JL, Griffin JM. Advancing translation of clinical research into practice and population health impact through implementation science. Mayo Clin Proc. 2024;99(4):665\u201376. https:\/\/doi.org\/10.1016\/j.mayocp.2023.02.005.","journal-title":"Mayo Clin Proc"},{"issue":"20","key":"8490_CR37","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/j.jacc.2024.08.068","volume":"84","author":"GC Van Spall Harriette","year":"2024","unstructured":"Van Spall Harriette GC, Desveaux L, Finch T, Lewis Cara C, Mensah George A, Rosenberg Y, et al. A guide to implementation science for phase 3 clinical trialists. J Am Coll Cardiol. 2024;84(20):2063\u201372. https:\/\/doi.org\/10.1016\/j.jacc.2024.08.068.","journal-title":"J Am Coll Cardiol"},{"key":"8490_CR38","doi-asserted-by":"publisher","unstructured":"Gohar F, Maschmeyer P, Mfarrej B, Lemaire M, Wedderburn LR, Roncarolo MG, et al. Driving medical innovation through interdisciplinarity: unique opportunities and challenges. Front. Med. 2019;6:- 2019. https:\/\/doi.org\/10.3389\/fmed.2019.00035.","DOI":"10.3389\/fmed.2019.00035"},{"key":"8490_CR39","unstructured":"National Academy of Sciences. National Academy of engineering, Institute of Medicine. Washington, DC: The National Academies Press; 2005. p. 332 p. Facilitating Interdisciplinary Research."},{"key":"8490_CR40","volume-title":"The Oxford 2011 levels of evidence","author":"J Howick","year":"2011","unstructured":"Howick J, Chalmers I, Glasziou P, Greenhalgh T, Heneghan C, Liberati A, et al. The Oxford 2011 levels of evidence. Oxford Centre for Evidence-Based Medicine; 2011."},{"key":"8490_CR41","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fmed.2019.00110","volume":"6","author":"M Battaglia","year":"2019","unstructured":"Battaglia M, Furlong P, Wulffraat NM, Bellutti Enders F. Improving the translational medicine process: moving patients from \u201cend-users\u201d to \u201cengaged collaborators\u201d. Front. Med. 2019;6:110. https:\/\/doi.org\/10.3389\/fmed.2019.00110.","journal-title":"Front. Med"},{"issue":"2","key":"8490_CR42","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/bmjinnov-2016-000157","volume":"3","author":"G Yeoman","year":"2017","unstructured":"Yeoman G, Furlong P, Seres M, Binder H, Chung H, Garzya V, et al. Defining patient centricity with patients for patients and caregivers: a collaborative endeavour. BMJ Innovations. 2017;3(2):76\u201383. https:\/\/doi.org\/10.1136\/bmjinnov-2016-000157.","journal-title":"BMJ Innovations"},{"issue":"1","key":"8490_CR43","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13690-023-01091-6","volume":"81","author":"R Azari","year":"2023","unstructured":"Azari R, Borisch B. What is public health? A scoping review. Arch Public Health. 2023;81(1):86. https:\/\/doi.org\/10.1186\/s13690-023-01091-6.","journal-title":"Arch Public Health"},{"issue":"9","key":"8490_CR44","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.2105\/AJPH.2008.156224","volume":"99","author":"RC Brownson","year":"2009","unstructured":"Brownson RC, Chriqui JF, Stamatakis KA. Understanding evidence-based public health policy. Am J Public Health. 2009;99(9):1576\u201383. https:\/\/doi.org\/10.2105\/AJPH.2008.156224.","journal-title":"Am J Public Health"},{"issue":"12","key":"8490_CR45","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.molmed.2022.09.002","volume":"28","author":"D Liskey","year":"2022","unstructured":"Liskey D, Cynkin L, Wolfram J. Patients as biomedical researchers. Trends Mol Med. 2022;28(12):1022\u201324. https:\/\/doi.org\/10.1016\/j.molmed.2022.09.002.","journal-title":"Trends Mol Med"},{"issue":"3","key":"8490_CR46","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.nhtm.2014.12.002","volume":"2","author":"RJ Cohrs","year":"2014","unstructured":"Cohrs RJ, Martin T, Ghahramani P, Bidaut L, Higgins PJ, Shahzad A. Translational medicine definition by the European society for translational Medicine. Eur J Criminol Mol & Clin Med. 2014;2(3):86\u201388. https:\/\/doi.org\/10.1016\/j.nhtm.2014.12.002.","journal-title":"Eur J Criminol Mol & Clin Med"},{"key":"8490_CR47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-94-007-2324-5_2","volume-title":"Assessment and teaching of 21st Century skills","author":"M Binkley","year":"2012","unstructured":"Binkley M, Erstad O, Herman J, Raizen S, Ripley M, Miller-Ricci M, et al. Defining twenty-first century skills. In: Griffin P, McGaw B, Care E, editors. Assessment and teaching of 21st Century skills. Dordrecht: Springer Netherlands; 2012. p. 17\u201366."},{"key":"8490_CR48","first-page":"0","volume-title":"Oxford textbook of global Public health","author":"MP Kelly","year":"2015","unstructured":"Kelly MP, Powell JE, Bartle N. Health needs assessment. In: Detels R, Gulliford M, Karim QA, Tan CC, editors. Oxford textbook of global Public health. Oxford University Press; 2015. p. 0."},{"issue":"1","key":"8490_CR49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41231-019-0050-7","volume":"4","author":"AA Seyhan","year":"2019","unstructured":"Seyhan AA. Lost in translation: the valley of death across preclinical and clinical divide \u2013 identification of problems and overcoming obstacles. Transl Med Commun. 2019;4(1):18. https:\/\/doi.org\/10.1186\/s41231-019-0050-7.","journal-title":"Transl Med Commun"},{"issue":"1","key":"8490_CR50","doi-asserted-by":"publisher","first-page":"104251","DOI":"10.1016\/j.drudis.2024.104251","volume":"30","author":"LT Bloem","year":"2025","unstructured":"Bloem LT, Leufkens HGM, Berends SE, Vreman RA, Hollak CEM, van Weely S, et al. Stimulating development of innovative medicines in the European Union: does a new definition for unmet medical need add value? Drug Discov. Today Today. 2025;30(1):104251. https:\/\/doi.org\/10.1016\/j.drudis.2024.104251.","journal-title":"Drug Discov. Today Today"},{"issue":"3","key":"8490_CR51","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/antibiotics8030131","volume":"8","author":"S Divya Ganeshan","year":"2019","unstructured":"Divya Ganeshan S, Hosseinidoust Z. Phage therapy with a focus on the human microbiota. Antibiot (Basel). 2019;8(3):131. https:\/\/doi.org\/10.3390\/antibiotics8030131.","journal-title":"Antibiot (Basel)"},{"issue":"1","key":"8490_CR52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40168-015-0094-5","volume":"3","author":"JR Marchesi","year":"2015","unstructured":"Marchesi JR, Ravel J. The vocabulary of microbiome research: a proposal. Microbiome. 2015;3(1):31. https:\/\/doi.org\/10.1186\/s40168-015-0094-5.","journal-title":"Microbiome"},{"issue":"5","key":"8490_CR53","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1205037","volume":"368","author":"van Nood E","year":"2013","unstructured":"van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos Wm, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368(5):407\u201315. https:\/\/doi.org\/10.1056\/NEJMoa1205037.","journal-title":"N Engl J Med"},{"issue":"8","key":"8490_CR54","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","volume":"14","author":"GR Gibson","year":"2017","unstructured":"Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, et al. Expert consensus document: the International scientific Association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14(8):491\u2013502. https:\/\/doi.org\/10.1038\/nrgastro.2017.75.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"8490_CR55","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","volume":"18","author":"S Salminen","year":"2021","unstructured":"Salminen S, Collado MC, Endo A, Hill C, Lebeer S, Quigley EMM, et al. The International scientific Association of probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. 2021;18(9):649\u201367. https:\/\/doi.org\/10.1038\/s41575-021-00440-6.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"8490_CR56","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41579-021-00667-9","volume":"20","author":"MT Sorbara","year":"2022","unstructured":"Sorbara MT, Pamer EG. Microbiome-based therapeutics. Nat Rev Microbiol. 2022;20(6):365\u201380. https:\/\/doi.org\/10.1038\/s41579-021-00667-9.","journal-title":"Nat Rev Microbiol"},{"issue":"22","key":"8490_CR57","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.3390\/cells14221779","volume":"14","author":"T Susiriwatananont","year":"2025","unstructured":"Susiriwatananont T, Eiamprapaporn P, Vazquez Roque M, Farraye FA, Perlman A, Chumsri S. The gut microbiome as a biomarker and therapeutic target of immune checkpoint inhibitors: a review for oncologists. Cells. 2025;14(22):1779. https:\/\/doi.org\/10.3390\/cells14221779.","journal-title":"Cells"},{"issue":"1","key":"8490_CR58","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40169-019-0232-y","volume":"8","author":"A Behrouzi","year":"2019","unstructured":"Behrouzi A, Nafari AH, Siadat SD. The significance of microbiome in personalized medicine. Clin Transl Med. 2019;8(1):16. https:\/\/doi.org\/10.1186\/s40169-019-0232-y.","journal-title":"Clin Transl Med"},{"issue":"12","key":"8490_CR59","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41579-019-0256-8","volume":"17","author":"AA Kolodziejczyk","year":"2019","unstructured":"Kolodziejczyk AA, Zheng D, Elinav E. Diet\u2013microbiota interactions and personalized nutrition. Nat Rev Microbiol. 2019;17(12):742\u201353. https:\/\/doi.org\/10.1038\/s41579-019-0256-8.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"8490_CR60","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13073-018-0525-6","volume":"10","author":"JF Petrosino","year":"2018","unstructured":"Petrosino JF. The microbiome in precision medicine: the way forward. Genome Med. 2018;10(1):12. https:\/\/doi.org\/10.1186\/s13073-018-0525-6.","journal-title":"Genome Med"},{"key":"8490_CR61","unstructured":". Leshner, AI, Terry, SF, Schultz, AM, Liverman, CT, editors. IOM (Institute of Medicine). The CTSA program at NIH: opportunities for advancing clinical and translational research. Washington, DC: The National Academies Press; 2013. p. 178 p."},{"issue":"1","key":"8490_CR62","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nm.2632","volume":"18","author":"RS Blumberg","year":"2012","unstructured":"Blumberg RS, Dittel B, Hafler D, von Herrath M, Nestle FO. Unraveling the autoimmune translational research process layer by layer. Nat Med. 2012;18(1):35\u201341. https:\/\/doi.org\/10.1038\/nm.2632.","journal-title":"Nat Med"},{"key":"8490_CR63","doi-asserted-by":"publisher","unstructured":"Concannon TW, Hughes MF, LaVertu AE, Garlick J, Rushforth AM. A review of reported stakeholder engagement in early-stage translational research. J. Clin. Trans. Sci. 2025;9(1):e24. https:\/\/doi.org\/10.1017\/cts.2024.620.","DOI":"10.1017\/cts.2024.620"},{"issue":"5","key":"8490_CR64","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jclinepi.2011.03.016","volume":"66","author":"BS Buckley","year":"2013","unstructured":"Buckley BS, Grant AM, Glazener CMA. Case study: a patient\u2013clinician collaboration that identified and prioritized evidence gaps and stimulated research development. J Educ Chang Clin Epidemiol. 2013;66(5):483\u201389. https:\/\/doi.org\/10.1016\/j.jclinepi.2011.03.016.","journal-title":"J Educ Chang Clin Epidemiol"},{"issue":"3","key":"8490_CR65","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1056\/NEJMp2112233","volume":"386","author":"LE Boulware","year":"2022","unstructured":"Boulware LE, Corbie G, Aguilar-Gaxiola S, Wilkins CH, Ruiz R, Vitale A, et al. Combating structural inequities \u2014 diversity, equity, and inclusion in clinical and translational research. N Engl J Med. 2022;386(3):201\u201303. https:\/\/doi.org\/10.1056\/NEJMp2112233.","journal-title":"N Engl J Med"},{"issue":"24","key":"8490_CR66","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1056\/NEJMsb1610128","volume":"375","author":"RM Califf","year":"2016","unstructured":"Califf RM, Robb MA, Bindman AB, Briggs JP, Collins FS, Conway PH, et al. Transforming evidence generation to support health and health care decisions. N Engl J Med. 2016;375(24):2395\u2013400. https:\/\/doi.org\/10.1056\/NEJMsb1610128.","journal-title":"N Engl J Med"},{"issue":"7197","key":"8490_CR67","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/453840a","volume":"453","author":"D Butler","year":"2008","unstructured":"Butler D. Translational research: crossing the valley of death. Nature. 2008;453(7197):840\u201342. https:\/\/doi.org\/10.1038\/453840a.","journal-title":"Nature"},{"issue":"2","key":"8490_CR68","doi-asserted-by":"publisher","first-page":"100948","DOI":"10.1016\/j.lanmic.2024.07.011","volume":"6","author":"J Rodriguez","year":"2025","unstructured":"Rodriguez J, Hassani Z, Alves Costa Silva C, Betsou F, Carraturo F, Fasano A, et al. State of the art and the future of microbiome-based biomarkers: a multidisciplinary Delphi consensus. LancetThe Lancet Microbe. 2025;6(2):100948. https:\/\/doi.org\/10.1016\/j.lanmic.2024.07.011.","journal-title":"LancetThe Lancet Microbe"},{"key":"8490_CR69","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.clnesp.2024.08.005","volume":"63","author":"V Shukla","year":"2024","unstructured":"Shukla V, Singh S, Verma S, Verma S, Rizvi AA, Abbas M. Targeting the microbiome to improve human health with the approach of personalized medicine: latest aspects and current updates. Clin Nutr ESPEN. 2024;63:813\u201320. https:\/\/doi.org\/10.1016\/j.clnesp.2024.08.005.","journal-title":"Clin Nutr ESPEN"},{"issue":"7","key":"8490_CR70","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41574-024-00966-0","volume":"20","author":"LMM Vliex","year":"2024","unstructured":"Vliex LMM, Penders J, Nauta A, Zoetendal EG, Blaak EE. The individual response to antibiotics and diet \u2014 insights into gut microbial resilience and host metabolism. Nat Rev Endocrinol. 2024;20(7):387\u201398. https:\/\/doi.org\/10.1038\/s41574-024-00966-0.","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"8490_CR71","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1136\/gutjnl-2016-313017","volume":"66","author":"G Cammarota","year":"2017","unstructured":"Cammarota G, Ianiro G, Tilg H, Rajilic-Stojanovic M, Kump P, Satokari R, et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut. 2017;66(4):569\u201380. https:\/\/doi.org\/10.1136\/gutjnl-2016-313017.","journal-title":"Gut"},{"issue":"6","key":"8490_CR72","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.chom.2022.04.016","volume":"30","author":"AM Armet","year":"2022","unstructured":"Armet AM, Deehan EC, O\u2019Sullivan AF, Mota JF, Field CJ, Prado CM, et al. Rethinking healthy eating in light of the gut microbiome. Cell Host Microbe. 2022;30(6):764\u201385. https:\/\/doi.org\/10.1016\/j.chom.2022.04.016.","journal-title":"Cell Host Microbe"},{"issue":"6","key":"8490_CR73","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1136\/gutjnl-2021-325214","volume":"71","author":"CJ Black","year":"2022","unstructured":"Black CJ, Staudacher HM, Ford AC. Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut. 2022;71(6):1117. https:\/\/doi.org\/10.1136\/gutjnl-2021-325214.","journal-title":"Gut"},{"issue":"8354","key":"8490_CR74","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S0140-6736(83)90753-5","volume":"322","author":"A Schwan","year":"1983","unstructured":"Schwan A. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of homologous faeces. Lancet. 1983;322(8354):845. https:\/\/doi.org\/10.1016\/S0140-6736(83)90753-5.","journal-title":"Lancet"},{"issue":"5","key":"8490_CR75","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1086\/367657","volume":"36","author":"J Aas","year":"2003","unstructured":"Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis. 2003;36(5):580\u201385. https:\/\/doi.org\/10.1086\/367657.","journal-title":"Clin Infect Dis"},{"key":"8490_CR76","doi-asserted-by":"publisher","unstructured":"McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious diseases society of America (IDSA) and society for healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):e1\u201348. https:\/\/doi.org\/10.1093\/cid\/cix1085.","DOI":"10.1093\/cid\/cix1085"},{"issue":"1","key":"8490_CR77","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/BF01308354","volume":"37","author":"BR Goldin","year":"1992","unstructured":"Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gualtieri L, Salminen S. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci. 1992;37(1):121\u201328. https:\/\/doi.org\/10.1007\/BF01308354.","journal-title":"Dig Dis Sci"},{"issue":"11","key":"8490_CR78","doi-asserted-by":"publisher","first-page":"4949","DOI":"10.1128\/AEM.65.11.4949-4956.1999","volume":"65","author":"CN Jacobsen","year":"1999","unstructured":"Jacobsen CN, Nielsen VR, Hayford AE, M\u00f8ller PL, Michaelsen KF, P\u00e6rregaard A, et al. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. By in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol. 1999;65(11):4949\u201356. https:\/\/doi.org\/10.1128\/AEM.65.11.4949-4956.1999.","journal-title":"Appl Environ Microbiol"},{"issue":"5","key":"8490_CR79","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1046\/j.1472-765X.1997.00140.x","volume":"24","author":"M Alander","year":"1997","unstructured":"Alander M, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, Von Wright A. Recovery of Lactobacillus rhamnosus GG from human colonic biopsies. Lett Appl Microbiol. 1997;24(5):361\u201364. https:\/\/doi.org\/10.1046\/j.1472-765X.1997.00140.x.","journal-title":"Lett Appl Microbiol"},{"issue":"5","key":"8490_CR80","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S0022-3476(99)70053-3","volume":"135","author":"JA Vanderhoof","year":"1999","unstructured":"Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Sport Hist Pediatrics. 1999;135(5):564\u201368. https:\/\/doi.org\/10.1016\/S0022-3476(99)70053-3.","journal-title":"J Sport Hist Pediatrics"},{"issue":"1","key":"8490_CR81","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/00005176-200001000-00018","volume":"30","author":"S Guandalini","year":"2000","unstructured":"Guandalini S, Pensabene L, Zikri MA, Dias JA, Casali LG, Hoekstra H, et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr. 2000;30(1):54\u201360. https:\/\/doi.org\/10.1097\/00005176-200001000-00018.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"8490_CR82","unstructured":"Food and Drug Administration (FDA). GRAS notice inventory - agency response letter. Gras Notice. 2002, No GRN 000049."},{"issue":"12","key":"8490_CR83","first-page":"4331","volume":"13","author":"H EPoB","year":"2015","unstructured":"EPoB H. Statement on the update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 3: suitability of taxonomic units notified to EFSA until September 2015. Efsa J. 2015;13(12):4331.","journal-title":"Efsa J"},{"issue":"5","key":"8490_CR84","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1099\/ijs.0.02873-0","volume":"54","author":"M Derrien","year":"2004","unstructured":"Derrien M, Vaughan EE, Plugge CM, de Vos WM. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Systematic Evol Microbiol. 2004;54(5):1469\u201376. https:\/\/doi.org\/10.1099\/ijs.0.02873-0.","journal-title":"Int J Systematic Evol Microbiol"},{"issue":"2","key":"8490_CR85","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/jat.4044","volume":"41","author":"C Druart","year":"2021","unstructured":"Druart C, Plovier H, Van Hul M, Brient A, Phipps KR, de Vos WM, et al. Toxicological safety evaluation of pasteurized Akkermansia muciniphila. J Appl Toxicol. 2021;41(2):276\u201390. https:\/\/doi.org\/10.1002\/jat.4044.","journal-title":"J Appl Toxicol"},{"issue":"7","key":"8490_CR86","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","volume":"25","author":"C Depommier","year":"2019","unstructured":"Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096\u2013103. https:\/\/doi.org\/10.1038\/s41591-019-0495-2.","journal-title":"Nat Med"},{"key":"8490_CR87","doi-asserted-by":"publisher","unstructured":"Mount S, Canfora EE, Jocken JW, Umanets A, Hul G, Coenjaerds M, et al. Pasteurized Akkermansia muciniphila MucT for weight loss maintenance in people with overweight and obesity: a controlled randomized trial. Nat Med. 2026. https:\/\/doi.org\/10.1038\/s41591-026-04394-7.","DOI":"10.1038\/s41591-026-04394-7"},{"key":"8490_CR88","doi-asserted-by":"publisher","unstructured":"Turck D, Bohn T, Castenmiller J, De Henauw S, Hirsch-Ernst KI, Maciuk A, et al. Safety of pasteurised Akkermansia muciniphila as a novel food pursuant to Regulation (EU) 2015\/2283. EFS2. 2021;19(9):e06780. https:\/\/doi.org\/10.2903\/j.efsa.2021.6780.","DOI":"10.2903\/j.efsa.2021.6780"},{"issue":"4","key":"8490_CR89","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1365-2672.1993.tb02790.x","volume":"75","author":"X Wang","year":"1993","unstructured":"Wang X, Gibson GR. Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J Appl Bacteriol. 1993;75(4):373\u201380. https:\/\/doi.org\/10.1111\/j.1365-2672.1993.tb02790.x.","journal-title":"J Appl Bacteriol"},{"issue":"4","key":"8490_CR90","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/0016-5085(95)90192-2","volume":"108","author":"GR Gibson","year":"1995","unstructured":"Gibson GR, Beatty ER, Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology. 1995;108(4):975\u201382. https:\/\/doi.org\/10.1016\/0016-5085(95)90192-2.","journal-title":"Gastroenterology"},{"issue":"11","key":"8490_CR91","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/S0271-5317(03)00164-7","volume":"23","author":"S Gr\u00e5sten","year":"2003","unstructured":"Gr\u00e5sten S, Liukkonen K-H, Chrevatidis A, El-Nezami H, Poutanen K, Mykk\u00e4nen H. Effects of wheat pentosan and inulin on the metabolic activity of fecal microbiota and on bowel function in healthy humans. Nutr Res. 2003;23(11):1503\u201314. https:\/\/doi.org\/10.1016\/S0271-5317(03)00164-7.","journal-title":"Nutr Res"},{"issue":"2","key":"8490_CR92","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3109\/09637486.2010.527323","volume":"62","author":"P Marteau","year":"2011","unstructured":"Marteau P, Jacobs H, Cazaubiel M, Signoret C, Prevel JM, Housez B. Effects of chicory inulin in constipated elderly people: a double-blind controlled trial. Int J Food Sci Nutr. 2011;62(2):164\u201370. https:\/\/doi.org\/10.3109\/09637486.2010.527323.","journal-title":"Int J Food Sci Nutr"},{"key":"8490_CR93","doi-asserted-by":"publisher","unstructured":"EFSA Panel on Dietetic Products N. Allergies. Scientific opinion on the substantiation of a health claim related to \u201cnative chicory inulin\u201d and maintenance of normal defecation by increasing stool frequency pursuant to article 13.5 of Regulation (EC) No 1924\/2006. Efsa J. 2015;13(1):3951. https:\/\/doi.org\/10.2903\/j.efsa.2015.3951.","DOI":"10.2903\/j.efsa.2015.3951"},{"issue":"15","key":"8490_CR94","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s40265-022-01797-x","volume":"82","author":"S Khanna","year":"2022","unstructured":"Khanna S, Assi M, Lee C, Yoho D, Louie T, Knapple W, et al. Efficacy and safety of RBX2660 in PUNCH CD3, a phase III, randomized, double-blind, placebo-controlled trial with a Bayesian primary analysis for the prevention of recurrent Clostridioides difficile infection. Drugs. 2022;82(15):1527\u201338. https:\/\/doi.org\/10.1007\/s40265-022-01797-x.","journal-title":"Drugs"},{"issue":"3","key":"8490_CR95","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1056\/NEJMoa2106516","volume":"386","author":"P Feuerstadt","year":"2022","unstructured":"Feuerstadt P, Louie TJ, Lashner B, Wang EEL, Diao L, Bryant JA, et al. SER-109, an oral microbiome therapy for recurrent Clostridioides difficile infection. N Engl J Med. 2022;386(3):220\u201329. https:\/\/doi.org\/10.1056\/NEJMoa2106516.","journal-title":"N Engl J Med"},{"issue":"5","key":"8490_CR96","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1128\/AEM.01226-07","volume":"74","author":"M Derrien","year":"2008","unstructured":"Derrien M, Collado MC, Ben-Amor K, Salminen S, de Vos WM. The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl Environ Microbiol. 2008;74(5):1646\u201348. https:\/\/doi.org\/10.1128\/AEM.01226-07.","journal-title":"Appl Environ Microbiol"},{"issue":"6","key":"8490_CR97","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3390\/nu17060948","volume":"17","author":"P Perrone","year":"2025","unstructured":"Perrone P, D\u2019Angelo S. Gut microbiota modulation through Mediterranean diet foods: implications for human health. Nutrients. 2025;17(6):948. https:\/\/doi.org\/10.3390\/nu17060948.","journal-title":"Nutrients"},{"issue":"3","key":"8490_CR98","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1021\/acsptsci.9b00022","volume":"2","author":"CT Gilliland","year":"2019","unstructured":"Gilliland CT, White J, Gee B, Kreeftmeijer-Vegter R, Bietrix F, Ussi AE, et al. The fundamental characteristics of a translational scientist. ACS Pharmacol Transl Sci. 2019;2(3):213\u201316. https:\/\/doi.org\/10.1021\/acsptsci.9b00022.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"8490_CR99","doi-asserted-by":"publisher","unstructured":"STEM education: to build a scientist. Nature. 2015;523(7560):371\u201373. https:\/\/doi.org\/10.1038\/nj7560-371a.","DOI":"10.1038\/nj7560-371a"},{"issue":"9","key":"8490_CR100","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/nm0909-1006","volume":"15","author":"S Albani","year":"2009","unstructured":"Albani S, Prakken B. The advancement of translational medicine\u2014from regional challenges to global solutions. Nat Med. 2009;15(9):1006\u201309. https:\/\/doi.org\/10.1038\/nm0909-1006.","journal-title":"Nat Med"},{"issue":"11","key":"8490_CR101","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1111\/cts.13390","volume":"15","author":"JM Faupel-Badger","year":"2022","unstructured":"Faupel-Badger JM, Vogel AL, Austin CP, Rutter JL. Advancing translational science education. Clin Transl Sci. 2022;15(11):2555\u201366. https:\/\/doi.org\/10.1111\/cts.13390.","journal-title":"Clin Transl Sci"},{"key":"8490_CR102","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fmed.2020.00069","volume":"7","author":"M Battaglia","year":"2020","unstructured":"Battaglia M, Albani S, Prakken B, Rosenblum ND. Editorial: the silent cry: how to turn translational medicine towards patients and unmet medical needs. Front. Med. 2020;7:69. https:\/\/doi.org\/10.3389\/fmed.2020.00069.","journal-title":"Front. Med"},{"key":"8490_CR103","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.trsl.2020.07.013","volume":"227","author":"D Ketcher","year":"2021","unstructured":"Ketcher D, Bidelman A, Le LQ, Otto AK, Lester DK, Amtmann-Beuttner KK, et al. Partnering patients, caregivers, and basic scientists: an engagement model that fosters patient- and family-centered research culture. Transl Res. 2021;227:64\u201374. https:\/\/doi.org\/10.1016\/j.trsl.2020.07.013.","journal-title":"Transl Res"},{"issue":"6","key":"8490_CR104","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ccell.2022.04.014","volume":"40","author":"A Thomas","year":"2022","unstructured":"Thomas A, Desai P, Takahashi N. Translational research: a patient-centered approach to bridge the valley of death. Cancer Cell. 2022;40(6):565\u201368. https:\/\/doi.org\/10.1016\/j.ccell.2022.04.014.","journal-title":"Cancer Cell"},{"key":"8490_CR105","doi-asserted-by":"publisher","unstructured":"LeClair AM, Kotzias V, Garlick J, Cole AM, Kwon SC, Lightfoot A, et al. Facilitating stakeholder engagement in early stage translational research. PLoS One. 2020;15(7):e0235400. https:\/\/doi.org\/10.1371\/journal.pone.0235400.","DOI":"10.1371\/journal.pone.0235400"},{"issue":"1","key":"8490_CR106","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12961-024-01175-x","volume":"22","author":"W Oortwijn","year":"2024","unstructured":"Oortwijn W, Reijmerink W, Bussemaker J. How to strengthen societal impact of research and innovation? Lessons learned from an explanatory research-on-research study on participatory knowledge infrastructures funded by the Netherlands Organization for health research and development. Health Res Policy Sys. 2024;22(1):81. https:\/\/doi.org\/10.1186\/s12961-024-01175-x.","journal-title":"Health Res Policy Sys"},{"issue":"20","key":"8490_CR107","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1001\/jama.283.20.2701","volume":"283","author":"EJ Emanuel","year":"2000","unstructured":"Emanuel EJ. What makes clinical research ethical? JAMA. 2000;283(20):2701\u201311. https:\/\/doi.org\/10.1001\/jama.283.20.2701.","journal-title":"JAMA"},{"issue":"9","key":"8490_CR108","doi-asserted-by":"publisher","first-page":"167","DOI":"10.21037\/atm.2018.04.46","volume":"6","author":"A Ciccarella","year":"2018","unstructured":"Ciccarella A, Staley AC, Franco AT. Transforming research: engaging patient advocates at all stages of cancer research. Ann Transl Med. 2018;6(9):167. https:\/\/doi.org\/10.21037\/atm.2018.04.46.","journal-title":"Ann. Transl. Med"},{"key":"8490_CR109","doi-asserted-by":"publisher","unstructured":"World Medical Association. World medical association declaration of helsinki: ethical principles for medical research involving human participants. JAMA. 2025;333(1):71\u201374. https:\/\/doi.org\/10.1001\/jama.2024.21972.","DOI":"10.1001\/jama.2024.21972"},{"issue":"1","key":"8490_CR110","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1001\/jama.2024.22077","volume":"333","author":"L Bloom","year":"2025","unstructured":"Bloom L. Revisiting the Declaration of Helsinki\u2014A patient-centered perspective. JAMA. 2025;333(1):22\u201323. https:\/\/doi.org\/10.1001\/jama.2024.22077.","journal-title":"JAMA"},{"issue":"1","key":"8490_CR111","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41591-022-02160-z","volume":"29","author":"V Subbiah","year":"2023","unstructured":"Subbiah V. The next generation of evidence-based medicine. Nat Med. 2023;29(1):49\u201358. https:\/\/doi.org\/10.1038\/s41591-022-02160-z.","journal-title":"Nat Med"},{"issue":"1","key":"8490_CR112","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1472-6963-14-89","volume":"14","author":"JP Domecq","year":"2014","unstructured":"Domecq JP, Prutsky G, Elraiyah T, Wang Z, Nabhan M, Shippee N, et al. Patient engagement in research: a systematic review. BMC Health Serv Res. 2014;14(1):89. https:\/\/doi.org\/10.1186\/1472-6963-14-89.","journal-title":"BMC Health Serv Res"},{"key":"8490_CR113","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fmed.2020.00093","volume":"7","author":"van Overbeeke E","year":"2020","unstructured":"van Overbeeke E, Vanbinst I, Jimenez-Moreno AC, Huys I, van Overbeeke E. Patient centricity in patient preference studies: the patient perspective. Front. Med. 2020;7:7. https:\/\/doi.org\/10.3389\/fmed.2020.00093.","journal-title":"Front. Med"},{"issue":"6","key":"8490_CR114","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41581-025-00940-7","volume":"21","author":"J Haydak","year":"2025","unstructured":"Haydak J, Wright J, Croxson PL, Daehn IS. Lived experience is essential for innovation in biomedical research. Nat Rev Nephrol. 2025;21(6):362\u201363. https:\/\/doi.org\/10.1038\/s41581-025-00940-7.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"8490_CR115","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1136\/ard-2022-223561","volume":"82","author":"CG Schoemaker","year":"2023","unstructured":"Schoemaker CG, Richards DP, de Wit M. Matching researchers\u2019 needs and patients\u2019 contributions: practical tips for meaningful patient engagement from the field of rheumatology. Ann Rheumatic Dis. 2023;82(3):312. https:\/\/doi.org\/10.1136\/ard-2022-223561.","journal-title":"Ann Rheumatic Dis"},{"key":"8490_CR116","doi-asserted-by":"publisher","unstructured":"Reed SD, Gouda P. Expanding the use and interpretation of patient-centric cardiovascular clinical trial endpoints. J Clin Trans Sci. 2025;9(1):e151. https:\/\/doi.org\/10.1017\/cts.2025.10054.","DOI":"10.1017\/cts.2025.10054"},{"issue":"7","key":"8490_CR117","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S2213-8587(25)00134-2","volume":"13","author":"K Khunti","year":"2025","unstructured":"Khunti K, Papamargaritis D, Aroda VR, Anjana RM, Kashyap SR. Re-evaluating the concept of remission in type 2 diabetes: a call for patient-centric approaches. Lancet Diabetes Endocrinol. 2025;13(7):615\u201334. https:\/\/doi.org\/10.1016\/S2213-8587(25)00134-2.","journal-title":"The Lancet Diabetes Endocrinol"},{"issue":"4","key":"8490_CR118","doi-asserted-by":"publisher","first-page":"102662","DOI":"10.1016\/j.jacadv.2026.102662","volume":"5","author":"MT Hills","year":"2026","unstructured":"Hills MT, Korjian S, Chi G, Natale A, Saxon L, Ferdinand KC, et al. Direct-to-participant enrollment in a virtual trial: lessons learned from the heartline study. JACC: Adv. 2026;5(4):102662. https:\/\/doi.org\/10.1016\/j.jacadv.2026.102662.","journal-title":"JACC: Adv"},{"key":"8490_CR119","doi-asserted-by":"publisher","unstructured":"Bolte LA, Klaassen MAY, Collij V, Vich Vila A, Fu J, van der Meulen TA, et al. Patient attitudes towards faecal sampling for gut microbiome studies and clinical care reveal positive engagement and room for improvement. PLoS One. 2021;16(4):e0249405. https:\/\/doi.org\/10.1371\/journal.pone.0249405.","DOI":"10.1371\/journal.pone.0249405"},{"issue":"10","key":"8490_CR120","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.molmed.2023.07.002","volume":"29","author":"M Parizadeh","year":"2023","unstructured":"Parizadeh M, Arrieta M-C. The global human gut microbiome: genes, lifestyles, and diet. Trends Mol Med. 2023;29(10):789\u2013801. https:\/\/doi.org\/10.1016\/j.molmed.2023.07.002.","journal-title":"Trends Mol Med"},{"issue":"11","key":"8490_CR121","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41579-024-01068-4","volume":"22","author":"FC Ross","year":"2024","unstructured":"Ross FC, Patangia D, Grimaud G, Lavelle A, Dempsey EM, Ross RP, et al. The interplay between diet and the gut microbiome: implications for health and disease. Nat Rev Microbiol. 2024;22(11):671\u201386. https:\/\/doi.org\/10.1038\/s41579-024-01068-4.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"8490_CR122","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s11606-021-07064-1","volume":"37","author":"EC Wong","year":"2022","unstructured":"Wong EC, Maher AR, Motala A, Ross R, Akinniranye O, Larkin J, et al. Methods for identifying health research gaps, needs, and priorities: a scoping review. J GEN Intern Med. 2022;37(1):198\u2013205. https:\/\/doi.org\/10.1007\/s11606-021-07064-1.","journal-title":"J GEN Intern Med"},{"key":"8490_CR123","volume-title":"Health research prioritization at WHO: an overview of methodology and high level analysis of WHO led health research priority setting exercises","author":"RF Viergever","year":"2010","unstructured":"Viergever RF, Terry R, Matsoso M. Health research prioritization at WHO: an overview of methodology and high level analysis of WHO led health research priority setting exercises. Geneva: World Health Organization; 2010."},{"issue":"4","key":"8490_CR124","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.cell.2024.12.017","volume":"188","author":"RJ Abdill","year":"2025","unstructured":"Abdill RJ, Graham SP, Rubinetti V, Ahmadian M, Hicks P, Chetty A, et al. Integration of 168, 000 samples reveals global patterns of the human gut microbiome. Cell. 2025;188(4):1100\u201318.e17. https:\/\/doi.org\/10.1016\/j.cell.2024.12.017.","journal-title":"Cell"},{"key":"8490_CR125","doi-asserted-by":"publisher","unstructured":"Huang Z, Liu K, Ma W, Li D, Mo T, Liu Q. The gut microbiome in human health and disease\u2014where are we and where are we going? A bibliometric analysis. Front Microbiol. 2022;13:- 2022. https:\/\/doi.org\/10.3389\/fmicb.2022.1018594.","DOI":"10.3389\/fmicb.2022.1018594"},{"issue":"11","key":"8490_CR126","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/s41564-018-0257-9","volume":"3","author":"A Palleja","year":"2018","unstructured":"Palleja A, Mikkelsen KH, Forslund SK, Kashani A, Allin KH, Nielsen T, et al. Recovery of gut microbiota of healthy adults following antibiotic exposure. Nat Microbiol. 2018;3(11):1255\u201365. https:\/\/doi.org\/10.1038\/s41564-018-0257-9.","journal-title":"Nat Microbiol"},{"issue":"3","key":"8490_CR127","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1093\/jac\/dky471","volume":"74","author":"BW Haak","year":"2019","unstructured":"Haak BW, Lankelma JM, Hugenholtz F, Belzer C, de Vos WM, Wiersinga WJ. Long-term impact of oral vancomycin, ciprofloxacin and metronidazole on the gut microbiota in healthy humans. J Antimicrob Chemother. 2019;74(3):782\u201386. https:\/\/doi.org\/10.1093\/jac\/dky471.","journal-title":"The J Antimicrob Chemother"},{"key":"8490_CR128","doi-asserted-by":"crossref","unstructured":"Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proceedings of the National Academy of Sciences. 2011: 4554\u201361, 108.","DOI":"10.1073\/pnas.1000087107"},{"issue":"3","key":"8490_CR129","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jclinepi.2012.09.015","volume":"66","author":"AS Jannot","year":"2013","unstructured":"Jannot AS, Agoritsas T, Gayet-Ageron A, Perneger TV. Citation bias favoring statistically significant studies was present in medical research. J Educ Chang Clin Epidemiol. 2013;66(3):296\u2013301. https:\/\/doi.org\/10.1016\/j.jclinepi.2012.09.015.","journal-title":"J Educ Chang Clin Epidemiol"},{"key":"8490_CR130","unstructured":"Zhou T, Zhao F. AI-empowered human microbiome research. Gut. 2025;gutjnl-2025\u2013335946."},{"issue":"11","key":"8490_CR131","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s41575-025-01100-9","volume":"22","author":"A Caminero","year":"2025","unstructured":"Caminero A, Tropini C, Valles-Colomer M, Shung DL, Gibbons SM, Surette MG, et al. Credible inferences in microbiome research: ensuring rigour, reproducibility and relevance in the era of AI. Nat Rev Gastroenterol Hepatol. 2025;22(11):788\u2013803. https:\/\/doi.org\/10.1038\/s41575-025-01100-9.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8490_CR132","doi-asserted-by":"publisher","unstructured":"Kadakia KT, Beckman AL, Ross JS, Krumholz HM. Leveraging open science to accelerate research. N Engl J Med. 2021;384(17):e61. https:\/\/doi.org\/10.1056\/NEJMp2034518.","DOI":"10.1056\/NEJMp2034518"},{"key":"8490_CR133","doi-asserted-by":"publisher","unstructured":"Schloss Patrick D. Identifying and overcoming threats to reproducibility, replicability, robustness, and generalizability in microbiome research. mBio. 2018;9(3):10.1128\/mbio.00525\u201318. https:\/\/doi.org\/10.1128\/mBio.00525-18.","DOI":"10.1128\/mBio.00525-18"},{"key":"8490_CR134","doi-asserted-by":"publisher","unstructured":"H H, Dewey L, Kirschman LJ. A host of issues: pseudoreplication in host\u2013microbiota studies. Appl Environ Microbiol. 2024;90(8):e0103324. https:\/\/doi.org\/10.1128\/aem.01033-24.","DOI":"10.1128\/aem.01033-24"},{"issue":"22","key":"8490_CR135","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1212\/WNL.0b013e318294b48a","volume":"80","author":"NF Schor","year":"2013","unstructured":"Schor NF. Why our patients (and we) need basic science research. Neurology. 2013;80(22):2070\u201375. https:\/\/doi.org\/10.1212\/WNL.0b013e318294b48a.","journal-title":"Neurology"},{"issue":"16","key":"8490_CR136","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.3390\/ijms20163973","volume":"20","author":"A Foletti","year":"2019","unstructured":"Foletti A, Fais S. Unexpected discoveries should be reconsidered in science\u2014A look to the past? IJMS. 2019;20(16):3973. https:\/\/doi.org\/10.3390\/ijms20163973.","journal-title":"IJMS"},{"issue":"1","key":"8490_CR137","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41467-022-28034-z","volume":"13","author":"JT Nearing","year":"2022","unstructured":"Nearing JT, Douglas GM, Hayes MG, MacDonald J, Desai DK, Allward N, et al. Microbiome differential abundance methods produce different results across 38 datasets. Nat Commun. 2022;13(1):342. https:\/\/doi.org\/10.1038\/s41467-022-28034-z.","journal-title":"Nat Commun"},{"issue":"1","key":"8490_CR138","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cell.2024.10.022","volume":"188","author":"S Nishijima","year":"2025","unstructured":"Nishijima S, Stankevic E, Aasmets O, Schmidt TSB, Nagata N, Keller MI, et al. Fecal microbial load is a major determinant of gut microbiome variation and a confounder for disease associations. Cell. 2025;188(1):222\u201336.e15. https:\/\/doi.org\/10.1016\/j.cell.2024.10.022.","journal-title":"Cell"},{"issue":"1","key":"8490_CR139","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s40168-021-01059-0","volume":"9","author":"JT Nearing","year":"2021","unstructured":"Nearing JT, Comeau AM, Langille MGI. Identifying biases and their potential solutions in human microbiome studies. Microbiome. 2021;9(1):113. https:\/\/doi.org\/10.1186\/s40168-021-01059-0.","journal-title":"Microbiome"},{"key":"8490_CR140","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-1-0716-5009-7_3","volume-title":"Best practice in microbiome research","author":"S Phillips","year":"2026","unstructured":"Phillips S, Watt R, Hughes S. Collection, storing, and processing of fecal samples for human microbiome research. In: Carding SR, editor. Best practice in microbiome research. New York, NY: Springer US; 2026. p. 33\u201344."},{"issue":"7","key":"8490_CR141","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1128\/AEM.68.7.3401-3407.2002","volume":"68","author":"EG Zoetendal","year":"2002","unstructured":"Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans ADL, de Vos WM. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol. 2002;68(7):3401\u201307. https:\/\/doi.org\/10.1128\/AEM.68.7.3401-3407.2002.","journal-title":"Appl Environ Microbiol"},{"key":"8490_CR142","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.mimet.2015.07.019","volume":"117","author":"M Aguirre","year":"2015","unstructured":"Aguirre M, Eck A, Koenen ME, Savelkoul PHM, Budding AE, Venema K. Evaluation of an optimal preparation of human standardized fecal inocula for in vitro fermentation studies. J Microbiological Methods. 2015;117:78\u201384. https:\/\/doi.org\/10.1016\/j.mimet.2015.07.019.","journal-title":"J Microbiological Methods"},{"issue":"11","key":"8490_CR143","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nbt.3960","volume":"35","author":"PI Costea","year":"2017","unstructured":"Costea PI, Zeller G, Sunagawa S, Pelletier E, Alberti A, Levenez F, et al. Towards standards for human fecal sample processing in metagenomic studies. Nat Biotechnol. 2017;35(11):1069\u201376. https:\/\/doi.org\/10.1038\/nbt.3960.","journal-title":"Nat Biotechnol"},{"key":"8490_CR144","doi-asserted-by":"publisher","unstructured":"Lecky DM, Hawking MK, McNulty CA. Patients\u2019 perspectives on providing a stool sample to their GP: a qualitative study. Br J Gen Pract. 2014;64(628):e684\u201393. https:\/\/doi.org\/10.3399\/bjgp14X682261.","DOI":"10.3399\/bjgp14X682261"},{"key":"8490_CR145","doi-asserted-by":"publisher","unstructured":"Vandeputte D, Tito RY, Vanleeuwen R, Falony G, Raes J. Practical considerations for large-scale gut microbiome studies. FEMS Microbiol Rev. 2017;41(Supplement_1):S154\u201367. https:\/\/doi.org\/10.1093\/femsre\/fux027.","DOI":"10.1093\/femsre\/fux027"},{"issue":"1","key":"8490_CR146","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1038\/s41467-024-46888-3","volume":"15","author":"E Muller","year":"2024","unstructured":"Muller E, Shiryan I, Borenstein E. Multi-omic integration of microbiome data for identifying disease-associated modules. Nat Commun. 2024;15(1):2621. https:\/\/doi.org\/10.1038\/s41467-024-46888-3.","journal-title":"Nat Commun"},{"key":"8490_CR147","doi-asserted-by":"publisher","unstructured":"Elzinga J, van der Oost J, de Vos WM, Smidt H. The use of defined microbial communities to model host-microbe interactions in the human gut. Microbiol Mol Biol Rev. 2019;83(2). https:\/\/doi.org\/10.1128\/MMBR.00054-18.","DOI":"10.1128\/MMBR.00054-18"},{"issue":"11","key":"8490_CR148","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1038\/s41396-018-0212-z","volume":"12","author":"EM Adamowicz","year":"2018","unstructured":"Adamowicz EM, Flynn J, Hunter RC, Harcombe WR. Cross-feeding modulates antibiotic tolerance in bacterial communities. ISME J. 2018;12(11):2723\u201335. https:\/\/doi.org\/10.1038\/s41396-018-0212-z.","journal-title":"The ISME J"},{"issue":"4","key":"8490_CR149","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/s41564-018-0123-9","volume":"3","author":"M Tramontano","year":"2018","unstructured":"Tramontano M, Andrejev S, Pruteanu M, Kl\u00fcnemann M, Kuhn M, Galardini M, et al. Nutritional preferences of human gut bacteria reveal their metabolic idiosyncrasies. Nat Microbiol. 2018;3(4):514\u201322. https:\/\/doi.org\/10.1038\/s41564-018-0123-9.","journal-title":"Nat Microbiol"},{"issue":"8","key":"8490_CR150","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.tim.2022.01.014","volume":"30","author":"S Moossavi","year":"2022","unstructured":"Moossavi S, Arrieta M-C, Sanati-Nezhad A, Bishehsari F. Gut-on-chip for ecological and causal human gut microbiome research. Trends Microbiol. 2022;30(8):710\u201321. https:\/\/doi.org\/10.1016\/j.tim.2022.01.014.","journal-title":"Trends Microbiol"},{"issue":"10","key":"8490_CR151","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1038\/s41596-021-00589-z","volume":"16","author":"J Puschhof","year":"2021","unstructured":"Puschhof J, Pleguezuelos-Manzano C, Martinez-Silgado A, Akkerman N, Saftien A, Boot C, et al. Intestinal organoid cocultures with microbes. Nat Protoc. 2021;16(10):4633\u201349. https:\/\/doi.org\/10.1038\/s41596-021-00589-z.","journal-title":"Nat Protoc"},{"issue":"1","key":"8490_CR152","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1038\/s41467-025-58319-y","volume":"16","author":"BJ Tillett","year":"2025","unstructured":"Tillett BJ, Dwiyanto J, Secombe KR, George T, Zhang V, Anderson D, et al. SCFA biotherapy delays diabetes in humanized gnotobiotic mice by remodeling mucosal homeostasis and metabolome. Nat Commun. 2025;16(1):2893. https:\/\/doi.org\/10.1038\/s41467-025-58319-y.","journal-title":"Nat Commun"},{"issue":"5","key":"8490_CR153","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41575-025-01041-3","volume":"22","author":"A Metwaly","year":"2025","unstructured":"Metwaly A, Kriaa A, Hassani Z, Carraturo F, Druart C, Trebicka J, et al. A consensus statement on establishing causality, therapeutic applications and the use of preclinical models in microbiome research. Nat Rev Gastroenterol Hepatol. 2025;22(5):343\u201356. https:\/\/doi.org\/10.1038\/s41575-025-01041-3.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"8490_CR154","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.chom.2021.12.008","volume":"30","author":"A Aranda-D\u00edaz","year":"2022","unstructured":"Aranda-D\u00edaz A, Ng KM, Thomsen T, Real-Ram\u00edrez I, Dahan D, Dittmar S, et al. Establishment and characterization of stable, diverse, fecal-derived in vitro microbial communities that model the intestinal microbiota. Cell Host Microbe. 2022;30(2):260\u201372.e5. https:\/\/doi.org\/10.1016\/j.chom.2021.12.008.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"8490_CR155","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12866-023-02915-9","volume":"23","author":"C Rachm\u00fchl","year":"2023","unstructured":"Rachm\u00fchl C, Lacroix C, Giorgetti A, Stoffel NU, Zimmermann MB, Brittenham GM, et al. Validation of a batch cultivation protocol for fecal microbiota of Kenyan infants. BMC Microbiol. 2023;23(1):174. https:\/\/doi.org\/10.1186\/s12866-023-02915-9.","journal-title":"BMC Microbiol"},{"key":"8490_CR156","doi-asserted-by":"publisher","unstructured":"Marini BL, Goodman AM, Perissinotti AJ. The essential role of randomised controlled trials. The Lancet Haematol. 2023;10(7):e486\u201387. https:\/\/doi.org\/10.1016\/S2352-3026(23)00130-8.","DOI":"10.1016\/S2352-3026(23)00130-8"},{"issue":"9300","key":"8490_CR157","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0140-6736(02)07283-5","volume":"359","author":"DA Grimes","year":"2002","unstructured":"Grimes DA, Schulz KF. An overview of clinical research: the lay of the land. Lancet. 2002;359(9300):57\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(02)07283-5.","journal-title":"Lancet"},{"issue":"21","key":"8490_CR158","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1001\/jama.2024.7741","volume":"331","author":"IJ Dahabreh","year":"2024","unstructured":"Dahabreh IJ, Bibbins-Domingo K. Causal inference about the effects of interventions from observational studies in medical journals. JAMA. 2024;331(21):1845\u201353. https:\/\/doi.org\/10.1001\/jama.2024.7741.","journal-title":"JAMA"},{"issue":"9","key":"8490_CR159","doi-asserted-by":"publisher","first-page":"100864","DOI":"10.1016\/S2666-5247(24)00079-X","volume":"5","author":"RFJ Kullberg","year":"2024","unstructured":"Kullberg RFJ, Wikki I, Haak BW, Kauko A, Galenkamp H, Peters-Sengers H, et al. Association between butyrate-producing gut bacteria and the risk of infectious disease hospitalisation: results from two observational, population-based microbiome studies. Lancet Microbe. 2024;5(9):100864. https:\/\/doi.org\/10.1016\/S2666-5247(24)00079-X.","journal-title":"LancetThe Lancet Microbe"},{"issue":"2","key":"8490_CR160","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.amjmed.2008.09.030","volume":"122","author":"SL Silverman","year":"2009","unstructured":"Silverman SL. From randomized controlled trials to observational studies. Am J Med. 2009;122(2):114\u201320. https:\/\/doi.org\/10.1016\/j.amjmed.2008.09.030.","journal-title":"Am J Med"},{"issue":"1","key":"8490_CR161","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41392-024-01760-0","volume":"9","author":"X-P Duan","year":"2024","unstructured":"Duan X-P, Qin B-D, Jiao X-D, Liu K, Wang Z, Zang Y-S. New clinical trial design in precision medicine: discovery, development and direction. Sig Transduct Target Ther. 2024;9(1):57. https:\/\/doi.org\/10.1038\/s41392-024-01760-0.","journal-title":"Sig Transduct Target Ther"},{"issue":"1","key":"8490_CR162","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-10-1","volume":"10","author":"L Thabane","year":"2010","unstructured":"Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, et al. A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol. 2010;10(1):1. https:\/\/doi.org\/10.1186\/1471-2288-10-1.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"8490_CR163","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1186\/s12967-025-06550-y","volume":"23","author":"van Kempen L","year":"2025","unstructured":"van Kempen L, de Vries Mc, de Koning Ejp, de Graeff N, van Kempen L, de Vries MC, et al. Who should be included in first-in-human trials? A systematic review of reasons. J Transl Med. 2025;23(1):649. https:\/\/doi.org\/10.1186\/s12967-025-06550-y.","journal-title":"J Transl Med"},{"issue":"1","key":"8490_CR164","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1471-2288-10-67","volume":"10","author":"M Arain","year":"2010","unstructured":"Arain M, Campbell MJ, Cooper CL, Lancaster GA. What is a pilot or feasibility study? A review of current practice and editorial policy. BMC Med Res Methodol. 2010;10(1):67. https:\/\/doi.org\/10.1186\/1471-2288-10-67.","journal-title":"BMC Med Res Methodol"},{"key":"8490_CR165","doi-asserted-by":"publisher","unstructured":"Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016;355:i 5239. https:\/\/doi.org\/10.1136\/bmj.i5239.","DOI":"10.1136\/bmj.i5239"},{"issue":"7758","key":"8490_CR166","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-019-1236-x","volume":"569","author":"W Zhou","year":"2019","unstructured":"Zhou W, Sailani MR, Contrepois K, Zhou Y, Ahadi S, Leopold SR, et al. Longitudinal multi-omics of host\u2013microbe dynamics in prediabetes. Nature. 2019;569(7758):663\u201371. https:\/\/doi.org\/10.1038\/s41586-019-1236-x.","journal-title":"Nature"},{"issue":"5","key":"8490_CR167","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.chom.2022.03.002","volume":"30","author":"LM Olsson","year":"2022","unstructured":"Olsson LM, Boulund F, Nilsson S, Khan MT, Gummesson A, Fagerberg L, et al. Dynamics of the normal gut microbiota: a longitudinal one-year population study in Sweden. Cell Host Microbe. 2022;30(5):726\u201339.e3. https:\/\/doi.org\/10.1016\/j.chom.2022.03.002.","journal-title":"Cell Host Microbe"},{"issue":"7834","key":"8490_CR168","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41586-020-2881-9","volume":"587","author":"I Vujkovic-Cvijin","year":"2020","unstructured":"Vujkovic-Cvijin I, Sklar J, Jiang L, Natarajan L, Knight R, Belkaid Y. Host variables confound gut microbiota studies of human disease. Nature. 2020;587(7834):448\u201354. https:\/\/doi.org\/10.1038\/s41586-020-2881-9.","journal-title":"Nature"},{"key":"8490_CR169","doi-asserted-by":"publisher","unstructured":"Damhorst GL, Adelman MW, Woodworth MH, Kraft CS. Current capabilities of gut microbiome\u2013based diagnostics and the promise of clinical application. The J Infect Dis. 2021;223(Suppl Supplement_3):SS270\u2013sS275. https:\/\/doi.org\/10.1093\/infdis\/jiaa689.","DOI":"10.1093\/infdis\/jiaa689"},{"issue":"1","key":"8490_CR170","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41575-021-00499-1","volume":"19","author":"DA Schupack","year":"2022","unstructured":"Schupack DA, Mars RAT, Voelker DH, Abeykoon JP, Kashyap PC. The promise of the gut microbiome as part of individualized treatment strategies. Nat Rev Gastroenterol Hepatol. 2022;19(1):7\u201325. https:\/\/doi.org\/10.1038\/s41575-021-00499-1.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"8490_CR171","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1136\/gutjnl-2020-323715","volume":"71","author":"KM Jardon","year":"2022","unstructured":"Jardon KM, Canfora EE, Goossens GH, Blaak EE. Dietary macronutrients and the gut microbiome: a precision nutrition approach to improve cardiometabolic health. Gut. 2022;71(6):1214\u201326. https:\/\/doi.org\/10.1136\/gutjnl-2020-323715.","journal-title":"Gut"},{"issue":"3","key":"8490_CR172","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2019.01.001","volume":"176","author":"E Pasolli","year":"2019","unstructured":"Pasolli E, Asnicar F, Manara S, Zolfo M, Karcher N, Armanini F, et al. Extensive unexplored human microbiome diversity revealed by over 150, 000 genomes from metagenomes spanning age, geography, and lifestyle. Cell. 2019;176(3):649\u201362.e20. https:\/\/doi.org\/10.1016\/j.cell.2019.01.001.","journal-title":"Cell"},{"key":"8490_CR173","doi-asserted-by":"publisher","unstructured":"Abdill RJ, Adamowicz EM, Blekhman R. Public human microbiome data are dominated by highly developed countries. PLoS Biol. 2022;20(2):e3001536. https:\/\/doi.org\/10.1371\/journal.pbio.3001536.","DOI":"10.1371\/journal.pbio.3001536"},{"issue":"7402","key":"8490_CR174","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature11053","volume":"486","author":"T Yatsunenko","year":"2012","unstructured":"Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486(7402):222\u201327. https:\/\/doi.org\/10.1038\/nature11053.","journal-title":"Nature"},{"issue":"4","key":"8490_CR175","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/s41591-026-04309-6","volume":"32","author":"DE Coral","year":"2026","unstructured":"Coral DE, Sargent JL, Carrasco-Zanini J, Coral LM, Deutsch AJ, Udler MS, et al. Five tenets for advancing evidence-based precision medicine. Nat Med. 2026;32(4):1211\u201322. https:\/\/doi.org\/10.1038\/s41591-026-04309-6.","journal-title":"Nat Med"},{"issue":"5","key":"8490_CR176","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/advances\/nmac075","volume":"13","author":"SM Gibbons","year":"2022","unstructured":"Gibbons SM, Gurry T, Lampe JW, Chakrabarti A, Dam V, Everard A, et al. Perspective: leveraging the gut microbiota to predict personalized responses to dietary, prebiotic, and probiotic interventions. Adv Nutr. 2022;13(5):1450\u201361. https:\/\/doi.org\/10.1093\/advances\/nmac075.","journal-title":"Adv Nutr"},{"issue":"2","key":"8490_CR177","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S2468-1253(24)00311-X","volume":"10","author":"S Porcari","year":"2025","unstructured":"Porcari S, Mullish BH, Asnicar F, Ng SC, Zhao L, Hansen R, et al. International consensus statement on microbiome testing in clinical practice. Lancet Gastroenterol Hepatol. 2025;10(2):154\u201367. https:\/\/doi.org\/10.1016\/S2468-1253(24)00311-X.","journal-title":"The Lancet Gastroenterol Hepatol"},{"issue":"1","key":"8490_CR178","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1038\/s41467-017-01973-8","volume":"8","author":"C Duvallet","year":"2017","unstructured":"Duvallet C, Gibbons SM, Gurry T, Irizarry RA, Alm EJ. Meta-analysis of gut microbiome studies identifies disease-specific and shared responses. Nat Commun. 2017;8(1):1784. https:\/\/doi.org\/10.1038\/s41467-017-01973-8.","journal-title":"Nat Commun"},{"key":"8490_CR179","doi-asserted-by":"publisher","unstructured":"Nilsen P, Sundemo D, Heintz F, Neher M, Nygren J, Svedberg P, et al. Towards evidence-based practice 2.0: leveraging artificial intelligence in healthcare. Front Health Serv. 2024;4:- 2024. https:\/\/doi.org\/10.3389\/frhs.2024.1368030.","DOI":"10.3389\/frhs.2024.1368030"},{"key":"8490_CR180","doi-asserted-by":"publisher","unstructured":"Duong DB, Holt B, Munoz C, Pollack TM. For and with people: announcing the Lancet global health Commission on people-centred care for universal health coverage and a call for commissioner nominations. Lancet Global Health. 2024;12(7):e1089\u201390. https:\/\/doi.org\/10.1016\/S2214-109X(24)00216-X.","DOI":"10.1016\/S2214-109X(24)00216-X"},{"issue":"3","key":"8490_CR181","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/nutrit\/nuad059","volume":"82","author":"S Dur\u00e3o","year":"2024","unstructured":"Dur\u00e3o S, Wilkinson M, Davids EL, Gerritsen A, Kredo T. Effects of policies or interventions that influence the school food environment on children\u2019s health and nonhealth outcomes: a systematic review. Nutr Rev. 2024;82(3):332\u201360. https:\/\/doi.org\/10.1093\/nutrit\/nuad059.","journal-title":"Nutr Rev"},{"issue":"10520","key":"8490_CR182","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1016\/S0140-6736(25)01567-3","volume":"406","author":"P Baker","year":"2025","unstructured":"Baker P, Slater S, White M, Wood B, Contreras A, Corval\u00e1n C, et al. Towards unified global action on ultra-processed foods: understanding commercial determinants, countering corporate power, and mobilising a public health response. Lancet. 2025;406(10520):2703\u201326. https:\/\/doi.org\/10.1016\/S0140-6736(25)01567-3.","journal-title":"Lancet"},{"issue":"4","key":"8490_CR183","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41579-024-01108-z","volume":"23","author":"NM Delzenne","year":"2025","unstructured":"Delzenne NM, Bindels LB, Neyrinck AM, Walter J. The gut microbiome and dietary fibres: implications in obesity, cardiometabolic diseases and cancer. Nat Rev Microbiol. 2025;23(4):225\u201338. https:\/\/doi.org\/10.1038\/s41579-024-01108-z.","journal-title":"Nat Rev Microbiol"},{"key":"8490_CR184","doi-asserted-by":"publisher","unstructured":"EFSA Panel on Dietetic Products N. Allergies. Scientific opinion on dietary Reference values for carbohydrates and dietary fibre. EFS2. 2010;8(3):1462. https:\/\/doi.org\/10.2903\/j.efsa.2010.1462.","DOI":"10.2903\/j.efsa.2010.1462"},{"issue":"3","key":"8490_CR185","doi-asserted-by":"publisher","first-page":"414","DOI":"10.2105\/AJPH.2015.302989","volume":"106","author":"KC O\u2019Doherty","year":"2016","unstructured":"O\u2019Doherty KC, Virani A, Wilcox ES. The human microbiome and public health: social and ethical considerations. Am J Public Health. 2016;106(3):414\u201320. https:\/\/doi.org\/10.2105\/AJPH.2015.302989.","journal-title":"Am J Public Health"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08490-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08490-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08490-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:58:02Z","timestamp":1789433882000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08490-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":185,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8490"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08490-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors read and approved the final version of the manuscript for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M.F. has expertise in Human Nutrition and Microbiology, with a particular focus on Clinical Nutrition and the Human Gut Microbiome. Her extensive experience across Education, Research, and Healthcare has enabled her to integrate these domains into a strongly translational and patient-centric research perspective, driven by a deep sense of care and responsibility to address unmet health needs she has directly witnessed during her professional journey. She considers patients not as \u201cthem,\u201d but as ourselves \u2013 our families, our friends, our colleagues, and our neighbours \u2013 in urgent need of better health solutions. Guided by empathy and compassion, she advocates for humanity in medical research and for research committed to improving the health of patients and society. H.S. has expertise in Microbial Ecology and is passionate about the role micro-organisms play in all facets of planetary health and dedicates his efforts towards deploying Microbiomes to address challenges we face regarding Human, Animal, Plant and Environmental Health. He holds a professorship in Complex Microbial Ecosystems at Wageningen University & Research, coordinates the large UNLOCK infrastructure for Microbiome Research and is Co-Chair of the Wageningen Microbiome Center. He is deeply convicted that scientific research as integral part of society can only flourish through adopting a strongly collaborative rather than competitive spirit.","order":3,"name":"Ethics","label":"Author information","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1183"}}